Listen "2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD"
Episode Synopsis
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
More episodes of the podcast Know Diabetes by Heart™ Professional Education Podcast Series
2022 Episode 7 – Life’s Essential 8™
04/10/2022
2022 Episode 6 – Three Basic Targets
27/07/2022
2022 Episode 5 – Initiative Update
04/03/2022